← Open Payments lookup

JOEL PECK: Open Payments

NPI 1760414049 · AIEA, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$5,015 in 124 payments from 12 companies in 2025. Trend: 2023 $2,192 · 2024 $2,938 · 2025 $5,015

Food & beverage: $4,880Education: $134
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)34$1,148
Teva Pharmaceuticals USA, Inc.14$953
Neurocrine BioSciences, Inc.19$765
E.R. Squibb & Sons, L.L.C.14$439
ABBVIE INC.4$437
Lundbeck LLC14$356
Alkermes, Inc.9$237
Otsuka America Pharmaceutical, Inc.7$194
Axsome Therapeutics, Inc.3$162
Vanda Pharmaceuticals Inc.4$142

Products named: CAPLYTA, INGREZZA, REXULTI, COBENFY, AUSTEDO XR, VRAYLAR, UZEDY, ARISTADA.

Industry payments across HI — which companies pay providers there.